Show simple item record

dc.contributor.authorSalunke , Smita
dc.contributor.authorLiu, Fang
dc.contributor.authorBatchelor, Hannah
dc.contributor.authorWalsh, Jenny
dc.contributor.authorTurner, Roy
dc.contributor.authorJu, Tzuchi
dc.contributor.authorTuleu, Catherine
dc.identifier.citationSalunke , S , Liu , F , Batchelor , H , Walsh , J , Turner , R , Ju , T & Tuleu , C 2017 , ' European Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children. ' , International Journal of Pharmaceutics , vol. 18 , no. 2 , pp. 257-262 .
dc.identifier.otherPURE: 11092051
dc.identifier.otherPURE UUID: 175d1d82-c077-43a6-925d-a23ebb3b4d9f
dc.identifier.otherScopus: 84978862950
dc.description© American Association of Pharmaceutical Scientists 2016, published by Springer US, available online at doi:
dc.description.abstractThe European Paediatric Formulation Initiative (EuPFI), founded in 2007, aims to promote and facilitate the preparation of better and safe medicines for children through linking research and information dissemination. It brings together the capabilities of the industry, academics, hospitals, and regulators within a common platform in order to scope the solid understanding of the major issues, which will underpin the progress towards the future of paediatric medicines we want.The EuPFI was formed in parallel to the adoption of regulations within the EU and USA and has served as a community that drives research and dissemination through publications and the organisation of annual conferences. The membership and reach of this group have grown since its inception in 2007 and continue to develop and evolve to meet the continuing needs and ambitions of research into and development of age appropriate medicines. Five diverse workstreams (age-appropriate medicines, Biopharmaceutics, Administration Devices, Excipients and Taste Assessment & Taste Masking (TATM)) direct specific workpackages on behalf of the EuPFI. Furthermore, EuPFI interacts with multiple diverse professional groups across the globe to ensure efficient working in the area of paediatric medicines. Strong commitment and active involvement of all EuPFI stakeholders have proved to be vital to effectively address knowledge gaps related to paediatric medicines, discuss potential areas for further research and identify issues that need more attention and analysis in the future.en
dc.relation.ispartofInternational Journal of Pharmaceutics
dc.subjectadministration devices
dc.subjectage appropriate
dc.subjecttaste assessment
dc.subjecttaste masking
dc.titleEuropean Paediatric Formulation Initiative (EuPFI)-Formulating Ideas for Better Medicines for Children.en
dc.contributor.institutionSchool of Life and Medical Sciences
dc.contributor.institutionDepartment of Pharmacy, Pharmacology and Postgraduate Medicine
dc.contributor.institutionCentre for Research into Topical Drug Delivery and Toxicology
dc.contributor.institutionPharmaceutical Analysis and Product Characterisation
dc.contributor.institutionBioadhesive Drug Delivery Group
dc.description.statusPeer reviewed
rioxxterms.typeJournal Article/Review

Files in this item


There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record